Litcius/Paper detail

Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)

Christine Tagliaferri Rael, Javier Lopez-Ríos, Stacey A. McKenna, Doyel Das, Curtis Dolezal, Elena Abascal, Alex Carballo‐Diéguez, Rebecca Schnall, Thomas J. Hope, José A. Bauermeister, Walter Bockting

2021AIDS and Behavior31 citationsDOIOpen Access PDF

Topics & Concepts

MedicineJudgementTransgender womenTransgenderHuman immunodeficiency virus (HIV)Pre-exposure prophylaxisPublic healthCompetence (human resources)Health psychologyHealth careFamily medicineNursingPsychologyMen who have sex with menSocial psychologyPolitical scienceEconomic growthPsychoanalysisSyphilisEconomicsLawHIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskLGBTQ Health, Identity, and Policy
Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP) | Litcius